|
|
|
Volumn 3, Issue 1, 2002, Pages 47-68
|
|
TRIPS, pharmaceuticals, developing countries, and the Doha "solution".
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
DRUG;
ESSENTIAL DRUG;
ARTICLE;
COMMERCIAL PHENOMENA;
DEVELOPING COUNTRY;
DRUG COST;
DRUG INDUSTRY;
ECONOMICS;
HEALTH;
HEALTH CARE AND PUBLIC HEALTH;
HUMAN;
INTERNATIONAL COOPERATION;
LEGAL ASPECT;
LICENSING;
PATENT;
PUBLIC HEALTH;
HEALTH CARE AND PUBLIC HEALTH;
COMMERCE;
DEVELOPING COUNTRIES;
DRUG COSTS;
DRUG INDUSTRY;
DRUGS, ESSENTIAL;
HUMANS;
INTERNATIONAL COOPERATION;
LICENSURE;
PATENTS;
PHARMACEUTICAL PREPARATIONS;
PUBLIC HEALTH;
WORLD HEALTH;
|
|
EID: 0012401548
PISSN: 15290816
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (69)
|
|
References (0)
|
